Heart failure is one of the leading causes of mortality, is a final common pathway of several cardiovascular diseases, and its treatment is a major concern in the science of cardiology. The aim of the present study was to compare the effect of addition of the coenzyme Q10 (CoQ10)/atorvastatin combination to standard congestive heart failure (CHF) treatment versus addition of atorvastatin alone on CHF outcomes. This study was a double-blind, randomized placebo-controlled trial. In the present study, 62 eligible patients were enrolled and randomized into 2 groups. In the intervention group patients received 10 mg atorvastatin daily plus 100 mg CoQ10 pearl supplement twice daily, and in the placebo group patients received 10 mg atorvastatin daily and the placebo of CoQ10 pearl for 4 months. For all patients echocardiography was performed and blood sample was obtained for determination of N-terminal B-type natriuretic peptide, total cholesterol, low density lipoprotein, erythrocyte sedimentation rate, and C-reactive protein levels. Echocardiography and laboratory test were repeated after 4 months. The New York Heart Association Function Class (NYHA FC) was also determined for each patient before and after the study period. Data analyses showed that ejection fraction (EF) and NYHA FC changes differ significantly between intervention and placebo group (P = 0.006 and P = 0.002, respectively). Changes in other parameters did not differ significantly between study groups. We deduce that combination of atorvastatin and CoQ10, as an adjunctive treatment of CHF, increase EF and improve NYHA FC in comparison with use of atorvastatin alone.
Introduction: Metastatic mucinous tumors present a unique diagnostic challenge for surgical pathologists due to their varied origins and potential diagnostic difficulties. Objectives: This study aimed to determine the frequency of SATB2 and CDX2 expression in metastatic mucinous tumors of ovarian and colonic origin. Materials and Methods: Paraffin blocks (n = 40) containing mucinous tumors of ovarian or colonic origin were collected from two educational hospitals affiliated with Isfahan University of Medical Sciences between 2009 and 2019. Prepared slides were stained for special AT-rich sequence-binding protein 2 (SATB2) and caudal type homeobox 2 (CDX2). The nuclear intensity of SATB2 or CDX2 staining was graded as follows: "0" for negative, "1+" for weak, "2+" for moderate, and "3+" for strong. The percentage of tumor staining was graded based on three categories: the majority of tumor staining (>50%) as "2", minority of tumor staining (5-49%) as "1", and negative staining (<5%) as "0". The final histologic score (H-score) was calculated by combining these intensity and percentage scores. Results: Both SATB2 and CDX2 were more frequently expressed in metastatic mucinous tumors of colonic origin compared to ovarian origin (65.5% versus 36.4% and 93.1% versus 72.7%, respectively), but the difference was not statistically significant. No significant differences were observed between metastatic mucinous tumors of colonic and ovarian origin regarding SATB2 and CDX2 nuclear intensity, percentage of tumor staining, and H-score. The sensitivity and specificity of CDX2 for differentiating between colonic and ovarian origin were 93.10% and 27.27%, respectively. The corresponding diagnostic values for SATB2 were 65.52% and 63.64%, in sequence. Conclusion: Neither of the two biomarkers, nor their combinations, demonstrated acceptable diagnostic values for distinguishing between metastatic mucinous tumors of ovarian and colonic origin.
Introduction: Cervical cancer is the most prevalent cancer associated with infection, which is provoked by the human papillomavirus (HPV). Natural vaginal microbes, known as vaginal microbiota, play an important role in regulating vaginal pH and are therefore important in the risk of cervical cancer. Trichomoniasis vaginalis is a genital infection that reports 250 million new infections worldwide each year and can increase the risk of developing cervical cancer in the general population. Objectives: The aim of this study was to investigate the relationship between cervical cancer and vaginal microbiota or trichomoniasis infection by examining several risk factors. Patients and Methods: This prospective case study was conducted from 2014 to 2018 from an educational pathology group in Isfahan, 200 samples are included in this study. The groups consist of women over 18 years old. The study group included patients with cervical cancer lesions. For participants, a questionnaire containing information about age, gender, abortion, age at first delivery, smoking or passive smoking and the result of Pap smear test (HPV, vaginal microbiota or Trichomonas) was completed. Results: Results suggested that cancerous and precancerous lesion development is not associated with parity, age at first child’s birth. However, it is statistically associated with lower vaginal microbiota, increased Trichomonas infection, old age, increased abortion rate, smoking, and the presence of HPV infection on Pap smear. Conclusion: Protection from harmful factors that affect a healthy vaginal microbiome, such as Trichomonas infections, can reduce the risk of cervical cancer.
Introduction: While Bowen’s disease (BD) and actinic keratosis (AK) are premalignant conditions, seborrheic keratosis (SK) is a benign lesion; therefore, the differentiation of these processes is of clinical importance. Objectives: This study aimed to assess the P16 and P53 markers expression in patients with pathological diagnoses of AK, BD, and SK. Materials and Methods: This cross-sectional study included all patients with the final pathological diagnosis of AK, SK, and BD between 2018 and 2022 in Al-Zahra hospital, Isfahan, Iran. Immunohistochemical staining using the EnVision method was done for all samples. The positive results of the P16 marker were interpreted as the block staining of the nucleus and cytoplasm, and in the case of the P53 marker, the positive results were interpreted as the block staining of the nucleus. Finally, we investigated and compared the expression pattern of P53 and P16 markers in three groups of BDs, SK, and AK. Results: The expression patterns of p16 and p53 varied notably among patients with AK, SK, and BD. In cases of AK and SK, p16 predominantly exhibited null or mosaic patterns, while BD was characterized by a block pattern. For p53, both AK and BD were more likely to display null or strong patterns, whereas SK was more frequently associated with a mosaic pattern. The diagnostic value of these markers indicated that p53 and p16 patterns could effectively assist in distinguishing BD from SK and AK. Conclusion: The distinct expression patterns of p16 and p53 in AK, SK, and BD underscore their potential as valuable diagnostic biomarkers. The differences in p16 and p53 patterns can aid in accurately differentiating between benign and precancerous lesions, supporting their incorporation into diagnostic protocols to improve patient management and treatment outcomes.
Introduction: Because of pathological overlaps, distinguishing well-differentiated liposarcoma (WDL) from lipoma is difficult. Objectives: The purpose of this study was to evaluate P16 as a differentiating marker for WDL and lipomas Materials and Methods: This cross-sectional study was performed on 38 pathology samples of lipoma and WDL in the department of pathology of Al-Zahra hospital, affiliated with Isfahan university of medical sciences, from 2011 to 2018. The studied samples were examined by immunohistochemistry (IHC) to determine the presence of P16. Results: Evaluation of IHC data showed that all of the lipoma samples (100%) had a score of 0 for IHC staining. In comparison, 84.2% of liposarcoma samples had a score of 3, and this difference was statistically significant (P<0.001). Evaluating the sensitivity and specificity of P16 gene expression showed that this marker has 84% sensitivity and 100% specificity for diagnosing liposarcoma (95% CI: 0.6042-0.9661). Conclusion: The use of p16 to differentiate WDL from lipoma has a sensitivity of 84% and a specificity of 100%, which could be very helpful in pathological practice.
18 September 2021 in Journal of Preventive Epidemiology
Introduction: Cervical cancer is the second most common type of cancer among women all over the world. Objectives: This study was conducted to demonstrate the effect of intrauterine devices (IUDs) on cervical cancer and precancerous lesions development. Patients and Methods: This study was conducted in two different hospitals in Isfahan on 200 samples, since 100 of them had results indicating cervical cancer, and the rest had no abnormal lesions. For both groups, a questionnaire was filled out for IUD users and some related risk factors such as age, parity, abortions, smoking, previous Pap smear results contained sexually transmitted diseases (STDs) infections and the contraception method. Results: In this study, more cases of IUD use were recorded in the control group. We found that the use of natural methods did not prevent the development of precancerous lesions. In the results of the Pap smear, a large number were recorded as having a history of human papillomavirus (HPV). Additionally, a high percentage of cervical cancer patients’ smoking or passive smoking. We also recorded that 53% had more than two children, while the percentages of women at the birth of their first child and who did not have an abortion were almost equal in the two groups. Conclusion: Our analysis demonstrated that IUD use is a contraceptive method with the capability of lowering the risk of cervical cancer progression. There is also an association between HPV infection, smoking, age, the number of parity and the usage of natural birth control methods with the development of cancerous lesion development.